Profil
Geoffrey Thomas Yarranton is the founder of Celscia Therapeutics, Inc. which was founded in 2003.
He held the title of Chief Executive Officer in 2004.
Dr. Yarranton's former jobs include being a Principal at Wyeth Holdings LLC and Celltech Group Plc, Senior Vice President-Research & Development at Coulter Pharmaceuticals, Inc., and Executive Vice President at Deltagen, Inc. He was also the CSO and Executive VP-Research & Development at Humanigen, Inc. from 2012 to 2015.
Dr. Yarranton received his undergraduate degree from the University of Leicester and his doctorate from The National Institute For Medical Research.
Anciens postes connus de Geoffrey Thomas Yarranton
| Sociétés | Poste | Fin |
|---|---|---|
Celscia Therapeutics, Inc.
Celscia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops antibody therapeutics for the treatment of cancer and inflammatory/autoimmune diseases | Fondateur | 01/01/2004 |
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Directeur Technique/Scientifique/R&D | - |
| DELTAGEN INC. | Corporate Officer/Principal | - |
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Corporate Officer/Principal | - |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Develops and manufactures pharmaceuticals | Corporate Officer/Principal | - |
Formation de Geoffrey Thomas Yarranton
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Process Industries |
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Deltagen, Inc.
Deltagen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery tools and services to the biopharmaceutical industry | Commercial Services |
Humanigen, Inc.
Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Celscia Therapeutics, Inc.
Celscia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops antibody therapeutics for the treatment of cancer and inflammatory/autoimmune diseases | Commercial Services |
University of Leicester
University of Leicester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The National Institute For Medical Research
The National Institute For Medical Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















